- 专利标题: PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
-
申请号: EP24151713.5申请日: 2020-12-17
-
公开(公告)号: EP4344702A3公开(公告)日: 2024-04-10
- 发明人: COTESTA, Simona , GERSPACHER, Marc , LEBLANC, Catherine , LIU, Bo , LORTHIOIS, Edwige Liliane Jeanne , MACHAUER, Rainer , MAH, Robert , MURA, Christophe , RIGOLLIER, Pascal , SCHNEIDER, Nadine , STUTZ, Stefan , VAUPEL, Andrea , WARIN, Nicolas , WILCKEN, Rainer
- 申请人: Novartis AG
- 申请人地址: CH 4056 Basel Lichtstrasse 35
- 代理机构: Mueller, Philippe
- 优先权: WOPCT/CN2020/125425 20201030
- 主分类号: A61P35/00
- IPC分类号: A61P35/00 ; C07D401/14 ; C07D403/04 ; C07D403/14 ; C07D405/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; A61K31/416
摘要:
The present invention provides a compound of formula (I) or a stereoisomer thereof, or an atropisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a stereoisomer thereof, or a pharmaceutically acceptable salt of an atropisomer thereof;
a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
公开/授权文献
- EP4344702A2 PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS 公开/授权日:2024-04-03
信息查询
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |